Trovafloxacin Mesylate is a broad-spectrum fluoroquinolone antibiotic. It was developed for immunology research (Pfizer). It can inhibit both Gram-positive and Gram-negative bacteria, and anaerobic organisms. The compound inhibits activity of DNA gyrase and topoisomerase, preventing the uncoiling of supercoiled DNA in various bacteria. It can inhibit pannexin1 (Panx1).
Trovafloxacin Mesylate is soluble in DMSO.
